查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1616681

2024-2032 年聚甘油癸二酸酯 (PGS) 市场机会、成长动力、产业趋势分析及预测

Polyglycerol Sebacate (PGS) Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球聚甘油癸二酸酯(PGS) 市值为6,549 万美元，预计2024 年至2032 年复合年增长率为10.6%。于製成的阀门和网状物等纺织品由聚乙烯和聚酯製成。它在组织工程以及神经和心血管组织修復方面尤其有价值。除了目前在组织支架中的应用外，PGS 还可以与挤出添加剂结合使用，并用于关节置换的骨移植。虽然目前 PGS 市场仍然较小且处于发展阶段，但其潜力巨大。

鑑于 PGS 能够以更好的灵活性模仿自然组织，因此最终可能取代聚乳酸 (PLA)、聚 L-乳酸 (PLLA)、聚乙醇酸 (PGA) 和聚己内酯 (PCL) 等其他生物材料。其柔软性、坚固性和成本效益使其成为其他可生物降解弹性体的有吸引力的替代品。 PGS 的应用包括神经引导、组织再生、血管重建和药物传输系统。到2032年，软凝胶市场预计将达到4,335万美元，复合年增长率为9.6%。和组织支架方面。此外，糊状 PGS 因其易于应用和定製而受到关注，使其成为再生医学和伤口护理的理想选择。组织工程领域在2023 年占据45% 的市场份额，价值2,947 万美元，预计到2032 年将以9% 的复合年增长率增长。组织修復的支架在再生医学。在药物传输领域，PGS 也因其受控降解特性而受到关注，从而实现更有针对性和创新的治疗系统。

在北美，PGS市场预计到2032年将达到7,434万美元，复合年增长率为12%。这一增长是由人口老化加剧以及肥胖和骨关节炎等生活方式疾病日益流行所推动的，尤其是在美国。该行业的其他参与者预计也将进入很快。此外，发展中地区（特别是东欧）的意识和需求不断提高，将进一步推动生物材料市场的发展。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 6549 万美元
预测值 1.4053 亿美元
复合年增长率 10.6%

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
    • 主要製造商
    • 经销商
    • 全行业利润率
  • 产业影响力
    • 成长动力
      • 医疗产业对组织工程和再生医学的产品需求不断增长
      • 对生物医学纺织品的需求不断增长，以改善医疗产业的癒合过程
    • 市场挑战
      • 多种产品替代品的可用性以及其性能属性的长期资料的可用性
    • 市场机会
      • 新机会
      • 成长潜力分析
  • 原料景观
    • 製造趋势
    • 技术演进
      • 永续製造
        • 绿色实践
        • 脱碳
    • 原材料的可持续性
    • 价格趋势（美元/吨），2021 - 2032
  • 法规和市场影响
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章：市场规模与预测：依形式，2021-2032

  • 主要趋势
  • 软凝胶
  • 贴上
  • 挤压製品
  • 其他的

第 6 章：市场规模与预测：按应用划分，2021-2032 年

  • 主要趋势
  • 组织工程
  • 药物输送
  • 黏合剂
  • 涂料
  • 其他的

第 7 章：市场规模与预测：按地区划分，2021-2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • MEA
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第 8 章：公司简介

  • BASF SE
  • Cambridge Polymers Group
  • Evonik Industries AG
  • Fuso Chemical Co., Ltd.
  • Orthofix International NV
  • Polymers LLC
  • PolySciTech (Akina, Inc.)
  • Resinex
  • Secant LLC
  • Sigma-Aldrich (Merck Group)
  • Synthecon Inc.
简介目录
Product Code: 3101

The Global Polyglycerol Sebacate (PGS) Market was valued at USD 65.49 million in 2023 and is expected to grow at 10.6% CAGR from 2024 to 2032. This versatile elastomer is widely used in bio-coating applications, particularly for textiles like valves and meshes made from polyethylene and polyester. It is especially valued in tissue engineering and nerve and cardiovascular tissue restoration. In addition to its current use in tissue scaffolding, PGS can be combined with additives for extrusion and employed in bone grafts for joint replacements. While the current market for PGS remains small and in a developmental phase, its potential is significant.

PGS could eventually replace other biomaterials like polylactic acid (PLA), poly-L-lactic acid (PLLA), poly glycolic acid (PGA), and polycaprolactone (PCL), given its ability to mimic natural tissue with better flexibility. Its softness, robustness, and cost-effectiveness make it an attractive alternative to other biodegradable elastomers. Applications of PGS include nerve guidance, tissue regeneration, blood vessel reconstruction, and drug delivery systems. The soft gel segment is expected to reach USD 43.35 million by 2032, growing at a 9.6% CAGR.PGS's flexibility and biocompatibility have made soft gels increasingly popular in medical applications, particularly in drug delivery and tissue scaffolding. Additionally, PGS in paste form is gaining attention for its easy application and customization, making it ideal for regenerative medicine and wound care. The tissue engineering segment held a 45% market share in 2023, valued at USD 29.47 million, and is projected to grow at a 9% CAGR through 2032. PGS's biocompatibility and adaptability have made it highly suitable for scaffolds that support cell growth and tissue repair in regenerative medicine. In the drug delivery space, PGS is also gaining traction due to its controlled degradation properties, enabling more targeted and innovative treatment systems.

In North America, the PGS market is expected to reach USD 74.34 million by 2032, growing at a 12% CAGR. This growth is driven by the rising aging population and the increasing prevalence of lifestyle diseases, such as obesity and osteoarthritis, particularly in the U.S. While Secant Group LLC currently leads the PGS market, other players in the biodegradable bone graft polymer industry are expected to enter soon. Moreover, increasing awareness and demand from developing regions, particularly in Eastern Europe, are set to boost the biomaterials market further.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$65.49 Million
Forecast Value$140.53 Million
CAGR10.6%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Key manufacturers
    • 3.1.2 Distributors
    • 3.1.3 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising product demand for tissue engineering and regenerative medicine in medical industry
      • 3.2.1.2 Growing demand for biomedical textiles to improve healing process in medical industry
    • 3.2.2 Market challenges
      • 3.2.2.1 Availability of several product substitutes and unavailability of long-term data on its performance attributes
    • 3.2.3 Market opportunity
      • 3.2.3.1 New opportunities
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
    • 3.3.2 Technology evolution
      • 3.3.2.1 Sustainable manufacturing
        • 3.3.2.1.1 Green practices
        • 3.3.2.1.2 Decarbonization
    • 3.3.3 Sustainability in raw materials
    • 3.3.4 Pricing trends (USD/Ton), 2021 - 2032
      • 3.3.4.1 North America
      • 3.3.4.2 Europe
      • 3.3.4.3 Asia Pacific
      • 3.3.4.4 Latin America
      • 3.3.4.5 Middle East & Africa
  • 3.4 Regulations & market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Form, 2021-2032 (USD Million, Tons)

  • 5.1 Key trends
  • 5.2 Soft gel
  • 5.3 Paste
  • 5.4 Extruded products
  • 5.5 Others

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)

  • 6.1 Key trends
  • 6.2 Tissue engineering
  • 6.3 Drug delivery
  • 6.4 Adhesives
  • 6.5 Coatings
  • 6.6 Others

Chapter 7 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
  • 7.6 MEA
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 South Africa

Chapter 8 Company Profiles

  • 8.1 BASF SE
  • 8.2 Cambridge Polymers Group
  • 8.3 Evonik Industries AG
  • 8.4 Fuso Chemical Co., Ltd.
  • 8.5 Orthofix International NV
  • 8.6 Polymers LLC
  • 8.7 PolySciTech (Akina, Inc.)
  • 8.8 Resinex
  • 8.9 Secant LLC
  • 8.10 Sigma-Aldrich (Merck Group)
  • 8.11 Synthecon Inc.